PFE vs. MRK
Compare and contrast key facts about Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFE or MRK.
Correlation
The correlation between PFE and MRK is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PFE vs. MRK - Performance Comparison
Loading data...
Key characteristics
PFE:
-0.67
MRK:
-1.51
PFE:
-0.76
MRK:
-2.07
PFE:
0.91
MRK:
0.73
PFE:
-0.26
MRK:
-0.93
PFE:
-1.12
MRK:
-1.74
PFE:
13.63%
MRK:
23.27%
PFE:
24.48%
MRK:
27.72%
PFE:
-58.96%
MRK:
-68.62%
PFE:
-56.22%
MRK:
-42.42%
Fundamentals
PFE:
$130.02B
MRK:
$192.42B
PFE:
$1.33
MRK:
$6.60
PFE:
16.56
MRK:
11.13
PFE:
0.58
MRK:
0.70
PFE:
2.08
MRK:
3.01
PFE:
1.44
MRK:
3.98
PFE:
$62.46B
MRK:
$63.92B
PFE:
$42.09B
MRK:
$51.75B
PFE:
$16.71B
MRK:
$27.30B
Returns By Period
In the year-to-date period, PFE achieves a -11.75% return, which is significantly higher than MRK's -24.16% return. Over the past 10 years, PFE has underperformed MRK with an annualized return of 0.58%, while MRK has yielded a comparatively higher 5.91% annualized return.
PFE
-11.75%
2.63%
-10.02%
-16.34%
-4.54%
0.58%
MRK
-24.16%
-4.58%
-22.68%
-41.53%
2.76%
5.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PFE vs. MRK — Risk-Adjusted Performance Rank
PFE
MRK
PFE vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
PFE vs. MRK - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 7.52%, more than MRK's 4.22% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 7.52% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
MRK Merck & Co., Inc. | 4.22% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.42% | 3.11% |
Drawdowns
PFE vs. MRK - Drawdown Comparison
The maximum PFE drawdown since its inception was -58.96%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for PFE and MRK. For additional features, visit the drawdowns tool.
Loading data...
Volatility
PFE vs. MRK - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 9.76%, while Merck & Co., Inc. (MRK) has a volatility of 12.24%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
PFE vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. MRK - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.